Health TrialsbyHealthPanel

Appendiceal Cancers

2

Review clinical trials related to Appendiceal Cancers. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers

This study will evaluate the safety and efficacy of NALIRIFOX per NAPOLI-3 regimen as first-line chemotherapy for patients with advanced small intestine and appendiceal cancers. Female or male patients aged 18 years, or older, with histopathologically or cytologically confirmed advanced mucinous or non-mucinous appendix cancer or advanced small intestine cancer will be eligible for participation in the study.

Participants needed: 22
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: The Methodist Hospital Research InstituteUpdated: Sep 25, 2026Locations: 2
Eligibility criteria

Male or female ≥18 years of age. [+5]

Absolute neutrophil count ≤1500 cells/mm3 [+10]

Read more
Status: Recruiting

An International Study on Pediatric Patients With Rare Tumors.

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.

Participants needed: 6,250
Trial details
Age: 0-18Biological sex: AllType: ObservationalSponsor: Azienda Ospedaliera di PadovaUpdated: Jul 18, 2025Locations: 1
Eligibility criteria

Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare T... [+1]

Absence of Written informed consent from the patient and/or the parent/legal gua...

Read more